{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:35:42Z","timestamp":1760060142828,"version":"build-2065373602"},"reference-count":45,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.clindermatol.2023.08.018","type":"journal-article","created":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T03:13:41Z","timestamp":1693451621000},"page":"622-627","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Hidradenitis suppurativa perspectives during the COVID-19 pandemic"],"prefix":"10.1016","volume":"41","author":[{"given":"Katrina","family":"Dovalovsky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Puyana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria M.","family":"Tsoukas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2023.08.018_bib0001","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/cid\/ciaa863","article-title":"COVID-19 in immunocompromised hosts: what we know so far","volume":"72","author":"Fung","year":"2021","journal-title":"Clin Infect Dis"},{"year":"2022","series-title":"Hidradenitis Suppurativa","author":"Ballard","key":"10.1016\/j.clindermatol.2023.08.018_bib0002"},{"key":"10.1016\/j.clindermatol.2023.08.018_bib0003","doi-asserted-by":"crossref","first-page":"5841","DOI":"10.3390\/jcm10245841","article-title":"Skin manifestations in psoriatic and HS patients in treatment with biologicals during the COVID-19 pandemic","volume":"10","author":"Rosi","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.clindermatol.2023.08.018_bib0004","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1056\/NEJMp2003539","article-title":"Virtually perfect? Telemedicine for COVID-19","volume":"382","author":"Hollander","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2023.08.018_bib0005","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/09546634.2020.1750557","article-title":"Teledermatology: a useful tool to fight COVID-19","volume":"31","author":"Villani","year":"2020","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.clindermatol.2023.08.018_bib0006","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jaad.2020.05.048","article-title":"The immediate impact of COVID-19 on US dermatology practices","volume":"83","author":"Litchman","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2023.08.018_bib0007","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.jaad.2020.02.030","article-title":"What are we doing in the dermatology outpatient department amidst the raging of the 2019 novel coronavirus?","volume":"82","author":"Chen","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2023.08.018_bib0008","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1016\/j.jaad.2020.03.037","article-title":"Dermatology practices as vectors for COVID-19 transmission: a call for immediate cessation of nonemergent dermatology visits","volume":"82","author":"Kwatra","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2023.08.018_bib0009","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jaad.2020.03.047","article-title":"Ethical outpatient dermatology care during the coronavirus (COVID-19) pandemic","volume":"82","author":"Pathoulas","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2023.08.018_bib0010","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1080\/09546634.2020.1781042","article-title":"Treating hidradenitis suppurativa during the COVID-19 pandemic: teledermatology exams of sensitive body areas","volume":"33","author":"Okeke","year":"2022","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.clindermatol.2023.08.018_bib0011","doi-asserted-by":"crossref","first-page":"e318","DOI":"10.1111\/ijd.15022","article-title":"Remote management of hidradenitis suppurativa in a pandemic era of COVID-19","volume":"59","author":"Kang","year":"2020","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2023.08.018_bib0012","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.jaad.2021.04.060","article-title":"Patient satisfaction with hidradenitis suppurativa televisits correlates with less severe disease","volume":"86","author":"Andriano","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2023.08.018_bib0013","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5070\/D3272052396","article-title":"Hidradenitis suppurativa patient perspectives during the COVID-19 pandemic","volume":"27","author":"Price","year":"2021","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2023.08.018_bib0014","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1016\/j.jaad.2020.04.142","article-title":"Hidradenitis suppurative: the importance of virtual outpatient care during the COVID-19 pandemic","volume":"83","author":"Shah","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2023.08.018_bib0015","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1111\/iwj.13772","article-title":"Impact of the COVID-19 pandemic on patients with hidradenitis suppurativa","volume":"19","author":"Fiocco","year":"2022","journal-title":"Int Wound J"},{"key":"10.1016\/j.clindermatol.2023.08.018_bib0016","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1001\/jamadermatol.2021.4741","article-title":"Patient impressions and outcomes after clinic-based hidradenitis suppurativa surgery","volume":"158","author":"Ravi","year":"2022","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2023.08.018_bib0017","unstructured":"UpToDate. COVID-19: issues related to wound care and telehealth management. Available at: https:\/\/www.uptodate.com\/contents\/covid-19-issues-related-to-wound-care-and-telehealth-management#H1632212724. Accessed June 15, 2022."},{"key":"10.1016\/j.clindermatol.2023.08.018_bib0018","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.38038","article-title":"Trends in US surgical procedures and health care system response to policies curtailing elective surgical operations during the COVID-19 pandemic","volume":"4","author":"Mattingly","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.clindermatol.2023.08.018_bib0019","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/j.jaad.2020.04.030","article-title":"Adalimumab for treatment of hidradenitis suppurativa during the COVID-19 pandemic: safety considerations","volume":"83","author":"Blaszczak","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2023.08.018_bib0020","doi-asserted-by":"crossref","first-page":"e13875","DOI":"10.1111\/dth.13875","article-title":"Management of patients with hidradenitis suppurative during the COVID-19 pandemic","volume":"33","author":"Montero-Vilchez","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2023.08.018_bib0021","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1684\/ejd.2020.3927","article-title":"Hidradenitis suppurativa and adalimumab in the COVID-19 era","volume":"30","author":"Marzano","year":"2020","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clindermatol.2023.08.018_bib0022","doi-asserted-by":"crossref","first-page":"136","DOI":"10.4274\/gulhane.galenos.2020.1495","article-title":"Temporary withdrawal of immunosuppressive treatments in patients with hidradenitis suppurativa during COVID-19 pandemic: a retrospective cross-sectional study","volume":"63","author":"Esme","year":"2021","journal-title":"Gulhane Medical J"},{"key":"10.1016\/j.clindermatol.2023.08.018_bib0023","doi-asserted-by":"crossref","first-page":"e14256","DOI":"10.1111\/dth.14256","article-title":"Management of patients with hidradenitis suppurativa during the COVID-19 pandemic: risk and benefit of immunomodulatory therapy","volume":"33","author":"Molinelli","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2023.08.018_bib0024","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jaad.2021.09.016","article-title":"Biologic therapy is not associated with increased COVID-19 severity in patients with hidradenitis suppurativa: initial findings from the Global Hidradenitis Suppurativa COVID-19 Registry","volume":"86","author":"Naik","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2023.08.018_bib0025","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1177\/1203475421997058","article-title":"Impact of treatment with TNF-\u03b1 inhibitors for hidradenitis suppurativa during the COVID-19 pandemic","volume":"25","author":"Benesh","year":"2021","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2023.08.018_bib0026","first-page":"105","article-title":"Coronavirus disease 2019 (COVID-19) in two hidradenitis suppurativa patients who are sisters treated with adalimumab","volume":"1","author":"G\u04e7n\u00fclal","year":"2021","journal-title":"J Dermatol Skin"},{"key":"10.1016\/j.clindermatol.2023.08.018_bib0027","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s40257-020-00514-2","article-title":"Managing cutaneous immune-mediate diseases during the COVID-19 pandemic","volume":"21","author":"Torres","year":"2020","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2023.08.018_bib0028","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1080\/09546634.2020.1769828","article-title":"Biologics for patients affected by hidradenitis suppurativa in the COVID-19 era: data from a referral center of Southern Italy","volume":"33","author":"Marasca","year":"2022","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.clindermatol.2023.08.018_bib0029","unstructured":"UpToDate. COVID-19: cutaneous manifestations and issues related to dermatologic care. Available at: https:\/\/www.uptodate.com\/contents\/covid-19-cutaneous-manifestations-and-issues-related-to-dermatologic-care#H3622472664. Accessed June 15, 2022."},{"key":"10.1016\/j.clindermatol.2023.08.018_bib0030","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/bjd.19345","article-title":"Global Hidradenitis Suppurativa COVID-19 Registry: a registry to inform data-driven management practices","volume":"183","author":"Naik","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2023.08.018_bib0031","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000521268","article-title":"Guidance on COVID-19 vaccination in hidradenitis suppurativa patients: a modified Delphi consensus of experts","volume":"8","author":"Rick","year":"2022","journal-title":"Skin Appendage Disord"},{"key":"10.1016\/j.clindermatol.2023.08.018_bib0032","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/bjd.19492","article-title":"COVID-19 in patients with hidradenitis suppurativa","volume":"184","author":"Lima","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2023.08.018_bib0033","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/exd.14475","article-title":"Low incidence of COVID-19 in hidradenitis suppurativa: How to interpret it?","volume":"31","author":"Dewigne","year":"2022","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2023.08.018_bib0034","doi-asserted-by":"crossref","first-page":"e309","DOI":"10.1016\/j.jaad.2020.06.986","article-title":"Experience in patients with hidradenitis suppurativa and COVID-19 symptoms","volume":"83","author":"Gal\u00e1n","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2023.08.018_bib0035","article-title":"The impact of the COVID-19 pandemic with hidradenitis suppurative being treated with adalimumab: evidence from real-world data","volume":"5","author":"Turkmen","year":"2020","journal-title":"Clin Dermatol J"},{"key":"10.1016\/j.clindermatol.2023.08.018_bib0036","first-page":"616","article-title":"May COVID-19 infection induce a paradoxical improvement of a non-responsive case of hidradenitis suppurativa?","volume":"156","author":"Caposiena Caro","year":"2021","journal-title":"Ital J Dermatol Venerol"},{"issue":"suppl 1","key":"10.1016\/j.clindermatol.2023.08.018_bib0037","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/exd.14339","article-title":"Anti-COVID-19 measurements for hidradenitis suppurativa patients","volume":"30","author":"Giamarellos-Bourboulis","year":"2021","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2023.08.018_bib0038","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jdcr.2022.03.008","article-title":"Hidradenitis suppurativa flares following COVID-19 vaccination: a case series","volume":"23","author":"Martora","year":"2022","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.clindermatol.2023.08.018_bib0039","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.jaad.2020.05.148","article-title":"Hidradenitis suppurativa through the lens of YouTube: a cross-sectional analysis","volume":"84","author":"Li","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2023.08.018_bib0040","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/ijd.13601","article-title":"Hidradenitis suppurativa gains increasing interest on World Wide Web: a source for patient information?","volume":"56","author":"Hessam","year":"2017","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2023.08.018_bib0041","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jaad.2019.12.024","article-title":"An internet-based survey study of patients with hidradenitis suppurativa: use of the internet for disease-related information","volume":"83","author":"Cole","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2023.08.018_bib0042","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00403-019-02027-3","article-title":"Hidradenitis suppurativa on Facebook: thematic and content analyses of patient support group","volume":"312","author":"Fisher","year":"2020","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.clindermatol.2023.08.018_bib0043","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1111\/bjd.18818","article-title":"Identifying barriers to care and research in hidradenitis suppurativa: findings from a patient engagement event","volume":"182","author":"Shukla","year":"2020","journal-title":"Br J Dermatol"},{"issue":"suppl 1","key":"10.1016\/j.clindermatol.2023.08.018_bib0044","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1093\/jbcr\/irac012.137","article-title":"506 Hidradenitis Suppurativa Reddit Support Group: finding new meaning in social media during the COVD-19 pandemic","volume":"43","author":"Yesantharao","year":"2022","journal-title":"J Burn Care Res"},{"key":"10.1016\/j.clindermatol.2023.08.018_bib0045","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ijwd.2020.04.009","article-title":"The role of virtual support groups for patients with hidradenitis suppurativa during the COVID-19 pandemic","volume":"6","author":"Stout","year":"2020","journal-title":"Int J Womens Dermatol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X23000974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X23000974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:22:07Z","timestamp":1760034127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X23000974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0738081X23000974"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2023.08.018","relation":{},"ISSN":["0738-081X"],"issn-type":[{"type":"print","value":"0738-081X"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hidradenitis suppurativa perspectives during the COVID-19 pandemic","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2023.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}